Joanne L. Viney files SEC Form 4 disclosures for Pandion Therapeutics, Inc.. They have made 1 open-market trade across 1 company since 2020, most recently 2023-04-01.
CIK 0001816744
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $22K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PAND | BUY | 2020-07-21 | 2020-07-21 | $18.00 | $22K | -6.7% | -2.2% | -38.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.